Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Ridgetech Inc. (RDGT)

HRT FINANCIAL LP — 10% Owner
Jul 1, 2026
Purchase
Shares
10,197
Price
$1.50
Total Value
$15.30K
Shares Held After
100,499
% of Holdings
10.1%
Jul 1, 2026
Purchase
Shares
3,959
Price
$3.30
Total Value
$13.06K
Shares Held After
82,556
% of Holdings
4.8%

Emergent BioSolutions Inc. (EBS)

Williams Paul Anthony — SVP, Products Business
Jul 1, 2026
Sale
Shares
3,000
Price
$8.40
Total Value
$25.20K
Shares Held After
159,098
% of Holdings
1.9%

Alpha Tau Medical Ltd. (DRTS)

Levy Raphi — Chief Financial Officer
Jul 1, 2026
Sale
Shares
2,127
Price
$13.02
Total Value
$27.69K
Shares Held After
90,180
% of Holdings
2.3%
Shares
3,553,410
Price
$84.43
Total Value
$300.01M
Shares Held After
1,131,954
% of Holdings
75.8%

Faeth Therapeutics, Inc. (FTH)

STEPHENSON BRIAN C — Chief Financial Officer
Jul 1, 2026
Purchase
Shares
600
Price
$24.22
Total Value
$14.53K
Shares Held After
46,688
% of Holdings
1.3%

Faeth Therapeutics, Inc. (FTH)

STEPHENSON BRIAN C — Chief Financial Officer
Jul 1, 2026
Purchase
Shares
4,400
Price
$23.40
Total Value
$102.96K
Shares Held After
46,088
% of Holdings
9.5%

REGENXBIO Inc. (RGNX)

PAKOLA STEVE — Chief Medical Officer
Jul 1, 2026
Sale
Shares
36,725
Price
$12.86
Total Value
$472.28K
Shares Held After
213,009
% of Holdings
14.7%
Jul 1, 2026
Sale
Shares
37,799
Price
$17.00
Total Value
$642.63K
Shares Held After
9,174,453
% of Holdings
0.4%

Oruka Therapeutics, Inc. (ORKA)

Sandler Laura Lee — Chief Operating Officer
Jul 1, 2026
Sale
Shares
500
Price
$95.47
Total Value
$47.74K
Shares Held After
236,384
% of Holdings
0.2%

Oruka Therapeutics, Inc. (ORKA)

Sandler Laura Lee — Chief Operating Officer
Jul 1, 2026
Sale
Shares
2,263
Price
$94.75
Total Value
$214.41K
Shares Held After
236,884
% of Holdings
0.9%

Oruka Therapeutics, Inc. (ORKA)

Sandler Laura Lee — Chief Operating Officer
Jul 1, 2026
Sale
Shares
2,237
Price
$93.85
Total Value
$209.93K
Shares Held After
239,147
% of Holdings
0.9%
Jul 1, 2026
Sale
Shares
49,666
Price
$240.25
Total Value
$11.93M
Shares Held After
7,229
% of Holdings
87.3%

Lexeo Therapeutics, Inc. (LXEO)

Otero Jose Manuel — Chief Operating Officer
Jul 1, 2026
Sale
Shares
4,666
Price
$4.48
Total Value
$20.90K
Shares Held After
137,482
% of Holdings
3.3%
Jul 1, 2026
Sale
Shares
313,476
Price
$5.32
Total Value
$1.67M
Shares Held After
9,609,825
% of Holdings
3.2%
Jul 1, 2026
Sale
Shares
25,947
Price
$4.48
Total Value
$116.24K
Shares Held After
377,817
% of Holdings
6.4%

Lexeo Therapeutics, Inc. (LXEO)

Bhalla Narinder Pal — Chief Medical Officer
Jul 1, 2026
Sale
Shares
22,306
Price
$4.42
Total Value
$98.59K
Shares Held After
82,194
% of Holdings
21.3%

Lexeo Therapeutics, Inc. (LXEO)

Tamayo Louis Edward — Chief Financial Officer
Jul 1, 2026
Sale
Shares
4,641
Price
$4.49
Total Value
$20.84K
Shares Held After
97,024
% of Holdings
4.6%

Alkermes plc. (ALKS)

Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Jul 1, 2026
Sale
Shares
700
Price
$52.13
Total Value
$36.49K
Shares Held After
73,389
% of Holdings
0.9%

Alkermes plc. (ALKS)

Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Jul 1, 2026
Sale
Shares
8,300
Price
$51.46
Total Value
$427.13K
Shares Held After
74,089
% of Holdings
10.1%

PRECIGEN, INC. (PGEN)

Thomasian Harry Jr. — Chief Financial Officer
Jul 1, 2026
Sale
Shares
171,429
Price
$5.53
Total Value
$948.00K
Shares Held After
354,535
% of Holdings
32.6%

Teladoc Health, Inc. (TDOC)

Bliss Kelly — President, U.S. Group Health
Jul 1, 2026
Sale
Shares
2,500
Price
$9.00
Total Value
$22.50K
Shares Held After
87,378
% of Holdings
2.8%

American Well Corp (AMWL)

Gotlib Phyllis — President, International
Jul 1, 2026
Sale
Shares
6,677
Price
$9.33
Total Value
$62.30K
Shares Held After
152,754
% of Holdings
4.2%

American Well Corp (AMWL)

HIRSCHHORN MARK — Chief Financial Officer
Jul 1, 2026
Sale
Shares
4,299
Price
$9.33
Total Value
$40.11K
Shares Held After
238,939
% of Holdings
1.8%

American Well Corp (AMWL)

Zamansky Dmitry — Chief Product & Tech. Officer
Jul 1, 2026
Sale
Shares
8,460
Price
$9.33
Total Value
$78.93K
Shares Held After
232,620
% of Holdings
3.5%

American Well Corp (AMWL)

McNeice Paul Francis — Chief Accounting Officer
Jul 1, 2026
Sale
Shares
653
Price
$9.33
Total Value
$6.09K
Shares Held After
9,851
% of Holdings
6.2%
Jul 1, 2026
Sale
Shares
25,000
Price
$24.00
Total Value
$600.00K
Shares Held After
1,103,816
% of Holdings
2.2%
Jul 1, 2026
Purchase
Shares
3,057
Price
$1.93
Total Value
$5.90K
Shares Held After
15,492
% of Holdings
19.7%
Jun 30, 2026
Sale
Shares
52,823
Price
$25.72
Total Value
$1.36M
Shares Held After
76,651
% of Holdings
40.8%

EyePoint, Inc. (EYPT)

Ribeiro Ramiro — Chief Medical Officer
Jun 30, 2026
Sale
Shares
2,438
Price
$15.02
Total Value
$36.61K
Shares Held After
0
% of Holdings
100.0%

EyePoint, Inc. (EYPT)

Ribeiro Ramiro — Chief Medical Officer
Jun 30, 2026
Sale
Shares
2,437
Price
$15.00
Total Value
$36.55K
Shares Held After
2,438
% of Holdings
50.0%

Beam Therapeutics Inc. (BEAM)

Simon Amy — Chief Medical Officer
Jun 30, 2026
Sale
Shares
373
Price
$34.73
Total Value
$12.95K
Shares Held After
102,363
% of Holdings
0.4%

4D Molecular Therapeutics, Inc. (FDMT)

Bizily Scott — Chief Legal Officer
Jun 30, 2026
Sale
Shares
6,566
Price
$14.00
Total Value
$91.92K
Shares Held After
8,617
% of Holdings
43.2%
Jun 30, 2026
Sale
Shares
6,000
Price
$14.80
Total Value
$88.80K
Shares Held After
48,604
% of Holdings
11.0%

Avalo Therapeutics, Inc. (AVTX)

Doyle Mittie — Chief Medical Officer
Jun 30, 2026
Sale
Shares
4,654
Price
$20.00
Total Value
$93.08K
Shares Held After
51,776
% of Holdings
8.2%

Immunome Inc. (IMNM)

Barchas Isaac — Director
Jun 30, 2026
Sale
Shares
101,050
Price
$21.12
Total Value
$2.13M
Shares Held After
308,504
% of Holdings
24.7%

Shattuck Labs, Inc. (STTK)

Shukla Abhinav A. — Chief Technical Officer
Jun 30, 2026
Sale
Shares
23,365
Price
$7.08
Total Value
$165.42K
Shares Held After
86,380
% of Holdings
21.3%

Omada Health, Inc. (OMDA)

Gracey Craig — Chief Accounting Officer
Jun 30, 2026
Sale
Shares
405
Price
$22.00
Total Value
$8.91K
Shares Held After
15,441
% of Holdings
2.6%

Omada Health, Inc. (OMDA)

Cook Steven L. — Chief Financial Officer
Jun 30, 2026
Sale
Shares
300
Price
$22.00
Total Value
$6.60K
Shares Held After
115,409
% of Holdings
0.3%

Royalty Pharma plc (RPRX)

Hite Christopher — EVP & Chairman, Partnering
Jun 30, 2026
Sale
Shares
600
Price
$57.09
Total Value
$34.25K
Shares Held After
40,000
% of Holdings
1.5%

Royalty Pharma plc (RPRX)

Hite Christopher — EVP & Chairman, Partnering
Jun 30, 2026
Sale
Shares
29,400
Price
$56.44
Total Value
$1.66M
Shares Held After
40,600
% of Holdings
42.0%

Royalty Pharma plc (RPRX)

Hite Christopher — EVP & Chairman, Partnering
Jun 30, 2026
Sale
Shares
2,554
Price
$57.10
Total Value
$145.84K
Shares Held After
459,399
% of Holdings
0.6%

Royalty Pharma plc (RPRX)

Hite Christopher — EVP & Chairman, Partnering
Jun 30, 2026
Sale
Shares
97,446
Price
$56.50
Total Value
$5.51M
Shares Held After
461,953
% of Holdings
17.4%

Shattuck Labs, Inc. (STTK)

Pandite Arundathy N. — Chief Medical Officer
Jun 30, 2026
Sale
Shares
30,000
Price
$7.01
Total Value
$210.30K
Shares Held After
136,219
% of Holdings
18.0%

Boundless Bio, Inc. (BOLD)

TANG KEVIN — 10% Owner
Jun 30, 2026
Purchase
Shares
100
Price
$2.50
Total Value
$250.00
Shares Held After
2,559,875
% of Holdings
0.0%

Boundless Bio, Inc. (BOLD)

TANG KEVIN — 10% Owner
Jun 30, 2026
Purchase
Shares
25,930
Price
$2.54
Total Value
$65.86K
Shares Held After
2,559,775
% of Holdings
1.0%

Relay Therapeutics, Inc. (RLAY)

Rahmer Peter — Chief Corporate Development Officer
Jun 30, 2026
Sale
Shares
50,000
Price
$19.09
Total Value
$954.50K
Shares Held After
225,857
% of Holdings
18.1%
Jun 30, 2026
Sale
Shares
20,000
Price
$8.84
Total Value
$176.80K
Shares Held After
845,559
% of Holdings
2.3%
Jun 30, 2026
Sale
Shares
10,000
Price
$34.90
Total Value
$349.00K
Shares Held After
42,963
% of Holdings
18.9%
Jun 30, 2026
Purchase
Shares
55
Price
$1.54
Total Value
$84.70
Shares Held After
72,590
% of Holdings
0.1%
Version: v26.5.2